Best practices for submitting to Lancet journals and open access options

Save

About this video

Looking for advice on how to prepare your manuscripts for publication in top-tier open access journals? You are invited to join our webinar with Pooja Jha, Editor-in-Chief of The Lancet Regional Health – Europe, to learn techniques and strategies to set yourself up for publishing success. Dr. Jha will also share details about the growth of the Lancet journals’ portfolio, with a focus on the growing number of open access options offered. Join this engaging webinar and get answers to your questions during the Q&A session.

The Lancet Regional Health – Europe is a new open access journal, part of The Lancet's global initiative to advocate for health-care quality and access in all regions of the world. The journal fosters the advance of clinical practice and health policy in the European region, with the ultimate goal of improving health outcomes. The journal aspires to increase the quality of regional and national health research. The Lancet Regional Health – Europe publishes high-quality original research that advocates change in, or illuminates, clinical practice and health policy in the European region. It also considers relevant reviews, commentaries, and opinion pieces. The journal invites submissions that are pertaining to regional health topics, including but not limited to prevention and management of infections and non-communicable diseases, improvement of healthy ageing, and reduction of health inequalities.

About the presenter

Thumbnail
Dr. Pooja Jha
|

Editor-in-Chief of The Lancet Regional Health – Europe

Dr. Pooja Jha is the Editor-in-Chief of The Lancet Regional Health – Europe. Prior to this role, she worked at Nature Research in Berlin as an editor of Nature Metabolism and contributed to the launch of the journal since 2018. Pooja has a BSc degree in Chemistry, Botany, Zoology, and a MSc degree in Medical Molecular Biology and Human Genetics from India. She obtained her PhD in Molecular Medicine at the Medical University of Graz (Austria) where she investigated the role of adipose tissue and liver cross-talk in NAFLD progression. This was followed by her postdoctoral research in computational genetics, mitochondrial supercomplexes, ageing, and metabolic diseases at EPFL (Switzerland).

Comments